Knopp Biosciences
Business Services · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2100 Wharton St Ste 615, Pittsburgh, Pen...Phone Number
(412) 488-1776Website
www.knoppbio.comRevenue
$5.2 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Knopp Biosciences
Knopp Biosciences LLC is a privately held company focused on drug discovery for immunological and neurological diseases. The company is developing dexpramipexole for eosinophilic asthma and has a Kv7 platform for epilepsy treatments, which is being advanced by Biohaven Pharmaceuticals. Founded in 2004, Knopp manages a portfolio of equity securities and product royalties. Their investor portal will provide updates and proprietary information to members starting Spring 2023.Explore more
Knopp Biosciences Org Chart
FL
Vice President and General Counsel
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Knopp Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Knopp Biosciences had a recent Job posting/layoffs
Earning: See what the market has to say on Knopp Biosciences recently announced quarterly report
Funding: Get notified immidiatlly once Knopp Biosciences has new funding data
Website visits: Recent activity has been detected on your website
Knopp Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Knopp Biosciences has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Knopp Biosciences launches new products
Check out if Knopp Biosciences is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Knopp Biosciences
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Knopp Biosciences
Compare insights from companies similar to Knopp Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
1-10
Private
-
2011
Mark KlevenSenior Vice President, Scientific Operations, Chief Operating Officer
Company Profile Activity
Activity Insights
Knopp Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Knopp Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Knopp Biosciences.
Knopp Biosciences financials insights
Gather financial insights about Knopp Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2006
Series A
$10M
2008
Series B
$10M
2012
Private Equity
$14.9M
2014
Debt
$23M
2020
Debt
$350K
Series C
$14M
Knopp Biosciences Tech Stack
A closer look at the technologies used by Knopp Biosciences
See more technologies
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Knopp Biosciences
Sign Up For FreeTo access detailed company insights
Knopp Biosciences LLC is a privately held company focused on drug discovery for immunological and neurological diseases. The company is developing dexpramipexole for eosinophilic asthma and has a Kv7 platform for epilepsy treatments, which is being advanced by Biohaven Pharmaceuticals. Founded in 2004, Knopp manages a portfolio of equity securities... Read More
